• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 464477 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417248564 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417248564 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Acadia Pharmaceuticals Rise Above Previous 52-Week High

Published on Thu, 03/21/2013 - 14:10
By Mallory Stone

Shares of Acadia Pharmaceuticals (NASDAQ:ACAD) traded today at $8.70, breaking its 52-week high. So far today approximately 18.6 million shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.

In the past 52 weeks, Acadia Pharmaceuticals share prices have been bracketed by a low of $1.29 and a high of $8.70 and are now at $8.67, 572% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 2.3% while the 50-day MA has advanced 1.6%.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Acadia Pharmaceuticals (NASDAQ:ACAD) is currently priced 3.1% above its average consensus analyst price target of $8.40. The stock should find initial support at its 50-day moving average (MA) of $6.02 and further support at its 200-day MA of $3.35.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Recent 52-Week High Exceeded in Shares o...

Shares of Xcel Energy (NYSE:XEL) traded at a new 52-week high today of $34.10. So far ...

Wyndham Worldwide: The Winning Streak Co...

Shares of Wyndham Worldwide (NYSE:WYN) traded today at $84.06, breaking its 52-week hig ...

Shares of Western Union Have Risen Above...

Western Union (NYSE:WU) traded at a new 52-week high today of $18.66. So far today app ...

Watch for Continued Gains in Shares of A...

Aqua America (NYSE:WTR) traded today at a new 52-week high of $26.90. Approximately 43 ...

W&T Offshore: The Losing Streak Continue...

Shares of W&T Offshore (NYSE:WTI) traded at a new 52-week low today of $7.52. Approxim ...

Shares of West Pharmaceutical Services R...

West Pharmaceutical Services (NYSE:WST) traded today at a new 52-week high of $53.28. ...

Warren Resources Looks to Continue to Tr...

Warren Resources (NASDAQ:WRES) traded at a new 52-week low today of $2.05. So far toda ...

Recent 52-Week High Exceeded in Shares o...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $52.77. Approximately 152, ...